Rambus (RMBS) closed the last trading session at $48.88, gaining 5.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $72.25 indicates a 47.8% upside potential.The average comprises eight short-term price targets ranging from a low of $55 to a high of $90, with a standard deviation of $9.97. While the lowest estimate indicates an increase of 12.5% from the current price level, the ...

In its upcoming report, Atmos Energy (ATO) is predicted by Wall Street analysts to post quarterly earnings of $2.92 per share, reflecting an increase of 2.5% compared to the same period last year. Revenues are forecasted to be $1.88 billion, representing a year-over-year increase of 14.4%.The consensus EPS estimate for the quarter has been revised 2.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates dur ...

Block (XYZ) came out with quarterly earnings of $0.56 per share, missing the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.85 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -36.36%. A quarter ago, it was expected that this mobile payments services provider would post earnings of $0.83 per share when it actually produced earnings of $0.71, delivering a surprise of -14.46%.Over the last four quart ...

Company Performance - iRhythm Technologies reported a quarterly loss of $0.95 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.89, but an improvement from a loss of $1.47 per share a year ago, indicating a year-over-year improvement [1] - The company posted revenues of $158.68 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.34% and showing an increase from $131.93 million in the same quarter last year [2] - Over the last four quarters, iRhythm Technologies has exceeded consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - iRhythm Technologies shares have increased by approximately 18.5% since the beginning of the year, contrasting with a decline of 5.3% in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.55 on revenues of $171.04 million, and for the current fiscal year, it is -$1.75 on revenues of $681.28 million [7] Industry Outlook - The Medical Info Systems industry, to which iRhythm Technologies belongs, is currently ranked in the top 18% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - The performance of iRhythm Technologies' stock may be influenced by the overall industry outlook, as empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions [5][8]

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Diebold Nixdorf, Incorporated (DBD) .Diebold Nixdorf, Incorporated currently has an average bro ...

Stagwell (STGW) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual investors often find i ...

Adherex Technologies Inc. (FENC) closed the last trading session at $6.19, gaining 11.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $13.20 indicates an 113.3% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $2.05. While the lowest estimate of $10 indicates a 61.6% increase from the current price level, the most optimistic ...

Shares of Comfort Systems (FIX) have gained 20.5% over the past four weeks to close the last trading session at $397.54, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $512.60 indicates a potential upside of 28.9%.The mean estimate comprises five short-term price targets with a standard deviation of $48.99. While the lowest estimate of $465 indicates a 17% increase from the cur ...

Tarsus Pharmaceuticals, Inc. (TARS) closed the last trading session at $50.90, gaining 4.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $67.13 indicates a 31.9% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $13.74. While the lowest estimate of $41 indicates a 19.5% decline from the current price level, the most optimist ...

Investors might want to bet on TripAdvisor (TRIP) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing e ...